bpc-157 & tb-500 20mg blend (10 mg) + (20 mg) Combo Vial: BPC-157/TB-500 (20mg vials)

Narrow support for peptide BPC-157 The committees first vote was far from unanimous but signaled narrow support for adding forms of the peptide BPC-157 to the compounding list

Research has explored their combined use in facilitating recovery following soft tissue trauma, surgery, or overuse injury, although further data is needed

In further embodiments, the invention encompasses a method of treating Parkinson and related neurological diseases by administering a therapeutically effective amount of one or more cations chosen from 1c, 1f, 1l, 1m, 2j, 2k, 2l, 2m, 2aa, 1c, 1f, 1l, 1m, 2j, 2k, 2l, 2m, and 2aa

Yao J, Miao Y, Zhang Y, Zhu L, Chen H, Wu X, Yang Y, Dai X, Hu Q, Wan M, Tang W

coli using a proprietary vector platform, specializes in Alzheimers and Parkinsons research targets such as beta-amyloid, tau, and alpha-synuclein, and has a published citation record in peer-reviewed neurodegeneration studies to back it up